CCL2 and idiopathic pulmonary fibrosis: Studies have demonstrated increased CCL2 in the circulation [29] and in the lungs [30,31] of IPF patients and there is evidence for a possible concentration gradient that may enable chemoattraction activity of CCL2 [31].